<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04924517</url>
  </required_header>
  <id_info>
    <org_study_id>WM_EEF_2021</org_study_id>
    <nct_id>NCT04924517</nct_id>
  </id_info>
  <brief_title>Extended Evening Fasting: Metabolic Health and Energy Balance</brief_title>
  <official_title>The Effect of 4 Days of Extended Evening Fasting on Metabolic Health, Energy Balance and Appetite</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nottingham Trent University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nottingham Trent University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare metabolic and feeding behaviour responses to 4 days of extended&#xD;
      evening fasting vs. a control trial&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Humans have evolved as a diurnal species, internally governed by the circadian system, which&#xD;
      dictates our hormone regulation. 'Chrononutrition' is a sub-discipline which combines food&#xD;
      timing with circadian physiology. The most popular method of time-restricted feeding in the&#xD;
      UK is to skip breakfast. However, data from several meta-analysis have shown that skipping&#xD;
      breakfast is associated with weight gain and insulin resistance, likely due to eating later&#xD;
      into the evening/night and therefore, out of sync with our circadian rhythm. Recent research&#xD;
      has shown that skipping dinner (evening fasting) has improved markers of cardio-metabolic&#xD;
      health in clinical populations, although these are typically from longer-term studies.&#xD;
      Despite these promising findings, it is not yet known whether these findings are population&#xD;
      specific.&#xD;
&#xD;
      Therefore, the investigators are interested in examining the metabolic response pre and post&#xD;
      intervention to see whether these promising findings can translate into a healthy population.&#xD;
      Furthermore, the investigators will be monitoring subjective appetite, energy intake and&#xD;
      expenditure to assess whether there is any short-term adaptation to a specific feeding&#xD;
      window.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 14, 2021</start_date>
  <completion_date type="Anticipated">June 14, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 14, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The study design is a randomised, controlled, crossover design in which participants undertake two conditions in a randomised order with at least four weeks in between trials.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycaemic control (Baseline)</measure>
    <time_frame>3.5 hours following the standardised breakfast meal on day 1.</time_frame>
    <description>A metabolic assessment lasting 3.5 hours will take place following a standardised, laboratory-based meal. The investigators will be taking periodic capillary and venous blood samples to measure post-prandial glucose and insulin, which together comprise 'glycaemic control'.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycaemic control (Post intervention)</measure>
    <time_frame>3.5 hours following the standardised breakfast meal on day 4.</time_frame>
    <description>A metabolic assessment lasting 3.5 hours will take place following a standardised, laboratory-based meal. The investigators will be taking periodic capillary and venous blood samples to measure post-prandial glucose and insulin, which together comprise 'glycaemic control'.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Energy Intake (Kilocalories)</measure>
    <time_frame>Day 1 to day 4.</time_frame>
    <description>Energy intake will be measured both during lab and outside of the laboratory when the participants are free-living. During lab, energy intake will be measured through ad-libitum feeding buffet where 20 minutes will be permitted to eat as much or as little as they desire, until 'comfortably full and satisfied', followed by post-feeding measurement of the remaining food. Outside of laboratory feeding will also be monitored through food diary's and weighing any investigator issued meals.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Energy expenditure</measure>
    <time_frame>Day 1 to day 4.</time_frame>
    <description>Energy expenditure will be measured via a chest-worn device (Actiheart) which combines heart rate and accelerometry to gauge calories expended.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cortisol awakening response</measure>
    <time_frame>Five samples will be collected by the participant within the first hour of waking on day 5.</time_frame>
    <description>The cortisol awakening response will be measured on the final morning of each trial.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale for Subjective Ratings of Appetite</measure>
    <time_frame>Every 2 hours between 8am-10pm from day 1 to day 4.</time_frame>
    <description>Subjective appetite will be measured on mobile devices via a software which replicates a 100mm visual analogue scale. The scale is divided into subscales of different appetite perceptions including: hunger, fullness, desire to eat and prospective food consumption.&#xD;
(i.e. from 0 - 100), with a rating of 100 fully supporting the perception and a rating of 0 fully opposing the perception.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acylated Ghrelin (appetite hormone)</measure>
    <time_frame>3.5 hours following the standardised breakfast meal on day 1 and day 4.</time_frame>
    <description>Acylated Ghrelin will be measured from the venous samples taken during the post-prandial period following the standardised meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PYY (appetite hormone)</measure>
    <time_frame>3.5 hours following the standardised breakfast meal on day 1 and day 4.</time_frame>
    <description>PYY will be measured from the venous samples taken during the post-prandial period following the standardised meal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carbohydrate oxidation</measure>
    <time_frame>During laboratory visits on day 1 and day 4 [baseline, 60min, 120min, 180min]</time_frame>
    <description>Investigators will be collecting expired air into Douglas bags, and measuring the VO2 and VCO2 concentration to calculate carbohydrate oxidation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat oxidation</measure>
    <time_frame>During laboratory visits on day 1 and day 4 [baseline, 60min, 120min, 180min]</time_frame>
    <description>Investigators will be collecting expired air into Douglas bags, and measuring the VO2 and VCO2 concentration to calculate fat oxidation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Extended Evening Fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will eat between 8am-4pm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will eat between 8am-8pm</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Extended Evening Fasting</intervention_name>
    <description>Participants will undertake 4 days of extended evening fasting (feeding between 8am-4pm). The participants will visit the laboratory on day 1, following a 16 h fast, where baseline measures will be taken and the response to a standardised meal will take place. The participant will also have an opportunity to feed ad-libitum before they leave the laboratory. The participant will continue to adhere to the feeding window on day 2 and day 3, although this will be in free-living conditions. On day 4, the participant will arrive back to the lab for post-intervention assessment, identical in format to day 1 with a metabolic assessment and energy intake assessment via a ad-libitum meal.</description>
    <arm_group_label>Extended Evening Fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Participants will undertake 4 days of a standard western feeding pattern (feeding between 8am-8pm). The participants will visit the laboratory on day 1, following a 12 h fast, where baseline measures will be taken and the response to a standardised meal will take place. The participant will also have an opportunity to feed ad-libitum before they leave the laboratory. The participant will continue to adhere to the feeding window on day 2 and day 3, although this will be in free-living conditions. On day 4, the participant will arrive back to the lab for post-intervention assessment, identical in format to day 1 with a metabolic assessment and energy intake assessment via a ad-libitum meal.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Non-smokers.&#xD;
&#xD;
               -  Have maintained a stable weight for 6 months (self-reported).&#xD;
&#xD;
               -  No history of gastric, digestive, cardiovascular or renal disease (self&#xD;
                  reported).&#xD;
&#xD;
               -  Female specific: must be using a monophasic, low dose combined OCP (containing&#xD;
                  less than 50Î¼g oestradiol and a synthetic progestin) OR females with regular&#xD;
                  menstrual cycles (self-reported).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe food allergies, dislike or intolerance of study foods or drinks.&#xD;
&#xD;
               -  Currently undergoing a lifestyle intervention (structured diet or exercise)&#xD;
&#xD;
               -  Diagnosis of a condition or currently undergoing treatment therapy known to&#xD;
                  affect glucose or lipid metabolism (e.g., type-2 diabetes, taking statins), or&#xD;
                  contraindications to exercise.&#xD;
&#xD;
               -  Use of medication or supplements that may affect hormone concentrations.&#xD;
&#xD;
               -  Excessive alcohol consumption (&gt;14 units/week).&#xD;
&#xD;
               -  Intensive training schedule (&gt;10 hours/week).&#xD;
&#xD;
               -  Female specific: currently pregnant or breastfeeding, the use of any hormonal&#xD;
                  contraception, and the self-reporting of short (&lt;24 d), long (&gt;35 d), or&#xD;
                  irregular menstrual cycles.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>William Mode, MRes</last_name>
    <phone>+447484751219</phone>
    <email>william_mode@hotmail.co.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Clayton, PhD</last_name>
    <phone>(+44) 115 848 5514</phone>
    <email>David.Clayton@ntu.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nottingham Trent University</name>
      <address>
        <city>Nottingham</city>
        <state>Greater London</state>
        <zip>NG11 8NS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>David Clayton, PhD</last_name>
      <phone>(+44) 115 848 5514</phone>
      <email>david.clayton@ntu.ac.uk</email>
    </contact>
    <investigator>
      <last_name>William Mode, MRes</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Clayton, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Hough, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ruth James, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ian Varley, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab. 2018 Jun 5;27(6):1212-1221.e3. doi: 10.1016/j.cmet.2018.04.010. Epub 2018 May 10.</citation>
    <PMID>29754952</PMID>
  </reference>
  <reference>
    <citation>Jamshed H, Beyl RA, Della Manna DL, Yang ES, Ravussin E, Peterson CM. Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans. Nutrients. 2019 May 30;11(6). pii: E1234. doi: 10.3390/nu11061234.</citation>
    <PMID>31151228</PMID>
  </reference>
  <reference>
    <citation>Ravussin E, Beyl RA, Poggiogalle E, Hsia DS, Peterson CM. Early Time-Restricted Feeding Reduces Appetite and Increases Fat Oxidation But Does Not Affect Energy Expenditure in Humans. Obesity (Silver Spring). 2019 Aug;27(8):1244-1254. doi: 10.1002/oby.22518.</citation>
    <PMID>31339000</PMID>
  </reference>
  <reference>
    <citation>Hutchison AT, Regmi P, Manoogian ENC, Fleischer JG, Wittert GA, Panda S, Heilbronn LK. Time-Restricted Feeding Improves Glucose Tolerance in Men at Risk for Type 2 Diabetes: A Randomized Crossover Trial. Obesity (Silver Spring). 2019 May;27(5):724-732. doi: 10.1002/oby.22449. Epub 2019 Apr 19.</citation>
    <PMID>31002478</PMID>
  </reference>
  <reference>
    <citation>Templeman I, Gonzalez JT, Thompson D, Betts JA. The role of intermittent fasting and meal timing in weight management and metabolic health. Proc Nutr Soc. 2020 Feb;79(1):76-87. doi: 10.1017/S0029665119000636. Epub 2019 Apr 26. Review.</citation>
    <PMID>31023390</PMID>
  </reference>
  <reference>
    <citation>Popkin BM. The nutrition transition and obesity in the developing world. J Nutr. 2001 Mar;131(3):871S-873S. Review.</citation>
    <PMID>11238777</PMID>
  </reference>
  <reference>
    <citation>Allison KC, Goel N. Timing of eating in adults across the weight spectrum: Metabolic factors and potential circadian mechanisms. Physiol Behav. 2018 Aug 1;192:158-166. doi: 10.1016/j.physbeh.2018.02.047. Epub 2018 Feb 24. Review.</citation>
    <PMID>29486170</PMID>
  </reference>
  <reference>
    <citation>St-Onge MP, Ard J, Baskin ML, Chiuve SE, Johnson HM, Kris-Etherton P, Varady K; American Heart Association Obesity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. Circulation. 2017 Feb 28;135(9):e96-e121. doi: 10.1161/CIR.0000000000000476. Epub 2017 Jan 30. Review.</citation>
    <PMID>28137935</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 24, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2021</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nottingham Trent University</investigator_affiliation>
    <investigator_full_name>William Mode</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Chrononutrition</keyword>
  <keyword>Energy balance</keyword>
  <keyword>Intermittent fasting</keyword>
  <keyword>Appetite hormones</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

